Hypoxia Causes Triglyceride Accumulation by HIF-1-mediated Stimulation of Lipin 1 Expression

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2012 Apr 3

PMID 22467849

Citations 76

Authors

Ilias Mylonis

Hiroshi Sembongi

Christina Befani

Panagiotis Liakos

Symeon Siniossoglou

George Simos

Affiliations

Soon will be listed here.

Abstract

Adaptation to hypoxia involves hypoxia-inducible transcription factors (HIFs) and requires reprogramming of cellular metabolism that is essential during both physiological and pathological processes. In contrast to the established role of HIF-1 in glucose metabolism, the involvement of HIFs and the molecular mechanisms concerning the effects of hypoxia on lipid metabolism are poorly characterized. Here, we report that exposure of human cells to hypoxia causes accumulation of triglycerides and lipid droplets. This is accompanied by induction of lipin 1, a phosphatidate phosphatase isoform that catalyzes the penultimate step in triglyceride biosynthesis, whereas lipin 2 remains unaffected. Hypoxic upregulation of lipin 1 expression involves predominantly HIF-1, which binds to a single distal hypoxia-responsive element in the lipin 1 gene promoter and causes its activation under low oxygen conditions. Accumulation of hypoxic triglycerides or lipid droplets can be blocked by siRNA-mediated silencing of lipin 1 expression or kaempferol-mediated inhibition of HIF-1. We conclude that direct control of lipin 1 transcription by HIF-1 is an important regulatory feature of lipid metabolism and its adaptation to hypoxia.

Citing Articles

Deciphering the anti-obesity mechanisms of pharmabiotic probiotics through advanced multiomics analysis.

Kim Y, Choi T, Jo S, Song W, Kim T, Kim M iScience. 2025; 28(2):111890.

PMID: 40017507 PMC: 11867264. DOI: 10.1016/j.isci.2025.111890.

Effect of roxadustat on lowering blood lipids in peritoneal dialysis patients with anemia.

Xu T, Ruan Y, Liu N, Wang Y, Zang X, Ma Y Ren Fail. 2025; 47(1):2460726.

PMID: 40000368 PMC: 11864003. DOI: 10.1080/0886022X.2025.2460726.

Alteration of Lipid Metabolism in Hypoxic Cancer Cells.

Gonzalez G, Osuji E, Fiur N, Clark M, Ma S, Lukov L Chem Biomed Imaging. 2025; 3(1):25-34.

PMID: 39886224 PMC: 11775851. DOI: 10.1021/cbmi.4c00050.

Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.

Zuo Q, Wu Y, Hu Y, Shao C, Liang Y, Chen L Heliyon. 2024; 10(9):e30807.

PMID: 38765144 PMC: 11101863. DOI: 10.1016/j.heliyon.2024.e30807.

Iron homeostasis and post-hemorrhagic hydrocephalus: a review.

Pan S, Hale A, Lemieux M, Raval D, Garton T, Sadler B Front Neurol. 2024; 14:1287559.

PMID: 38283681 PMC: 10811254. DOI: 10.3389/fneur.2023.1287559.

References

Unger R, Clark G, Scherer P, Orci L . Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta. 2009; 1801(3):209-14. DOI: 10.1016/j.bbalip.2009.10.006. View

Finck B, Gropler M, Chen Z, Leone T, Croce M, Harris T . Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006; 4(3):199-210. DOI: 10.1016/j.cmet.2006.08.005. View

Neuschwander-Tetri B . Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010; 52(2):774-88. DOI: 10.1002/hep.23719. View

Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel A, Nizet V . NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008; 453(7196):807-11. PMC: 2669289. DOI: 10.1038/nature06905. View

Epstein A, Gleadle J, McNeill L, Hewitson K, ORourke J, Mole D . C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107(1):43-54. DOI: 10.1016/s0092-8674(01)00507-4. View

Greenspan P, Mayer E, Fowler S . Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 1985; 100(3):965-73. PMC: 2113505. DOI: 10.1083/jcb.100.3.965. View

Semenza G . Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011; 365(6):537-47. DOI: 10.1056/NEJMra1011165. View

Mylonis I, Lakka A, Tsakalof A, Simos G . The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions. Biochem Biophys Res Commun. 2010; 398(1):74-8. DOI: 10.1016/j.bbrc.2010.06.038. View

Kamura T, Sato S, Iwai K, Conaway R, Conaway J . Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A. 2000; 97(19):10430-5. PMC: 27041. DOI: 10.1073/pnas.190332597. View

10.

Donkor J, Sariahmetoglu M, Dewald J, Brindley D, Reue K . Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem. 2006; 282(6):3450-7. DOI: 10.1074/jbc.M610745200. View

11.

Fakas S, Qiu Y, Dixon J, Han G, Ruggles K, Garbarino J . Phosphatidate phosphatase activity plays key role in protection against fatty acid-induced toxicity in yeast. J Biol Chem. 2011; 286(33):29074-29085. PMC: 3190715. DOI: 10.1074/jbc.M111.258798. View

12.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

13.

Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit C . Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab. 2009; 9(6):512-24. DOI: 10.1016/j.cmet.2009.05.005. View

14.

Lyberopoulou A, Venieris E, Mylonis I, Chachami G, Pappas I, Simos G . MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity. Cell Physiol Biochem. 2007; 20(6):995-1006. DOI: 10.1159/000110460. View

15.

Peterfy M, Phan J, Xu P, Reue K . Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001; 27(1):121-4. DOI: 10.1038/83685. View

16.

Kallio P, Wilson W, OBrien S, Makino Y, Poellinger L . Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem. 1999; 274(10):6519-25. DOI: 10.1074/jbc.274.10.6519. View

17.

Brahimi-Horn M, Bellot G, Pouyssegur J . Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev. 2010; 21(1):67-72. DOI: 10.1016/j.gde.2010.10.006. View

18.

Huss J, Levy F, Kelly D . Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem. 2001; 276(29):27605-12. DOI: 10.1074/jbc.M100277200. View

19.

Flugel D, Gorlach A, Michiels C, Kietzmann T . Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol. 2007; 27(9):3253-65. PMC: 1899978. DOI: 10.1128/MCB.00015-07. View

20.

Turkish A, Sturley S . Regulation of triglyceride metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT". Am J Physiol Gastrointest Liver Physiol. 2006; 292(4):G953-7. DOI: 10.1152/ajpgi.00509.2006. View